| For: | Lv Y, Luo WJ. Dapagliflozin and sacubitril on myocardial microperfusion in patients with post-acute myocardial infarction heart failure and type 2 diabetes. World J Clin Cases 2024; 12(22): 5008-5015 [PMID: 39109007 DOI: 10.12998/wjcc.v12.i22.5008] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i22/5008.htm |
| Number | Citing Articles |
| 1 |
Dong-Hua Liu, Xiao-Ming Dong, Wen-Jie Long. Advancing cardiovascular outcomes with dapagliflozin and sacubitril in post-acute myocardial infarction heart failure and type 2 diabetes mellitus. World Journal of Clinical Cases 2024; 12(36): 6935-6938 doi: 10.12998/wjcc.v12.i36.6935
Abstract(530) |
Core Tip(536) |
Full Article(HTML)(2118)
|
Full Article (PDF)-343K(174)
|
Full Article with Cover (PDF)-582K(129)
|
Full Article (Word)-22K(7)
|
Full Article (XML)-51K(122)
|
Audio-410K(8)
|
Peer-Review Report-236K(114)
|
Answering Reviewers-71K(116)
|
Times Cited (2)
|
Total Visits (2550)
|
Open
|
| 2 |
Jia Xu, Yuanhong Jie, Tao Dong, Qi Li, Xiaobing Liu. Modulation of circulating inflammatory biomarkers by SGLT2 inhibitors in diabetic patients with acute myocardial infarction: A quantitative meta-analysis of laboratory evidence. Journal of Medical Biochemistry 2026; 45(6) doi: 10.5937/jomb0-65034
|
| 3 |
Jianwen Wen, Jiebin Huang, Quan Sun, Wei Ding. Development and validation of a nomogram model incorporating serum GDF-15, MEG3, and HSP-70 for predicting short-term outcomes in patients with acute myocardial infarction: a retrospective study. European Journal of Medical Research 2026; 31(1) doi: 10.1186/s40001-026-04224-z
|